The Family History as a Tool to Identify Patients at Risk for Dilated Cardiomyopathy

2008 ◽  
Vol 23 (1) ◽  
pp. 41-44 ◽  
Author(s):  
Deirdre Nauman ◽  
Ana Morales ◽  
Jason Cowan ◽  
Jimena Dagua ◽  
Ray E. Hershberger
2010 ◽  
Vol 118 (1-3) ◽  
pp. 69-75 ◽  
Author(s):  
Danielle A. Schlosser ◽  
Jamie L. Zinberg ◽  
Rachel L. Loewy ◽  
Shannon Casey-Cannon ◽  
Mary P. O'Brien ◽  
...  

1992 ◽  
Vol 14 (1) ◽  
pp. 6-9 ◽  
Author(s):  
Marie Boutté

In 1975 an unusual family reunion was held at Children's Hospital in Oakland, California. The large Joseph family had gathered for the first time. One of their members had finally taken the family secret to the National Genetics Foundation and asked for help with the unique disease that for many years had been passed in their family from one generation to the next. The National Genetics Foundation sent a team of neurologists and geneticists to the reunion and held the first screening clinic for what became known as Joseph's Disease, and later as Machado-Joseph disease (MJD). Diagnosis of those afflicted with the disease was made from neurological examinations, and at-risk status was determined from family history and genealogical analysis.


2010 ◽  
Vol 152A (3) ◽  
pp. 607-612 ◽  
Author(s):  
Jolien S. Ruiter ◽  
Karin Berkenbosch-Nieuwhof ◽  
Maarten P. van den Berg ◽  
Rene van Dijk ◽  
Berrie Middel ◽  
...  

2018 ◽  
Author(s):  
Martin Tobi ◽  
Fadi Antaki ◽  
MaryAnn Rambus ◽  
Michael Lawson ◽  
Daniel Ezekwudo

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. e12003-e12003
Author(s):  
Ivan Marquez-Rodas ◽  
Sara Perez Ramirez ◽  
Mercedes Cavanagh Podesta ◽  
Beatriz Moya ◽  
Ana Belen Ruperez Blanco ◽  
...  

e12003 Background: A comprehensive family history and consideration of the criteria for hereditary cancer risk are essential for oncology practice, since patients and relatives at risk could benefit from further genetic counseling (GC). The objective of this work is to compare the family history record and the hereditary cancer perception risk according to national cancer institute (NCI) criteria before and after the creation of a heredofamilial cancer unit (HFCU). Methods: We retrospectively analyze the clinical records from new incoming patients of our medical oncology service in two cohorts: Cohort 1, from January 2009 to December 2009 (before HFCU creation); and cohort 2, from May 2010 to August 2010 (first four months after HFCU creation). Family history record (yes/no) and NCI general hereditary cancer criteria (unusually early age; one or more first-degree relatives affected with the same or a related tumor; synchronous, bilateral or metachronous cancer in the same individual; atypical presentations; suggestive pathology report) were collected. Results were compared using chi-square test. p <0.05 was considered significant. Results: The table summarizes the results. In cohort 1, 28% (175/621) of clinical records contained the family history, while in cohort 2 this percentage increased to 54% (92/171), (p<0.001). 17% (106/621) patients in cohort 1 and 23% (40/171) in cohort 2, met NCI risk criteria (N.S.) In cohort 1, 13% (14/106) of these patients were referred to GC, while in cohort 2 this percentage increased to 38% (15/40) (p<0.01). Conclusions: The creation of a multidisciplinary HFCU significantly increased the quality of family history records and the referral of patients at risk to GC. However, the percentages still remain limited and further efforts must be made in order to remark the importance of family history in oncology. [Table: see text]


2005 ◽  
Vol 173 (4S) ◽  
pp. 455-455
Author(s):  
Anthony V. D’Amico ◽  
Ming-Hui Chen ◽  
Kimberly A. Roehl ◽  
William J. Catalona

Sign in / Sign up

Export Citation Format

Share Document